title: A simple and sensitive assay for the quantitative analysis of rivastigmine and its metabolite NAP 226-90 in human EDTA plasma using coupled liquid chromatography and tandem mass spectrometry.
abstract: A sensitive and specific high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS/MS) assay for the determination of rivastigmine and its major metabolite NAP 226-90 is presented. A 100 microL plasma aliquot was spiked with a structural analogue of rivastigmine as internal standard (PKF214-976-AE-1) and proteins were precipitated by adding 200 microL of methanol. After centrifugation a volume of 100 microL of the clear supernatant was mixed with 100 microL of methanol/water (30:70, v/v) and volumes of 25 microL were injected onto the HPLC system. Separation was acquired on a 150 x 2.0 mm i.d. Gemini C18 column using a gradient system with 10 mM ammonium hydroxide and methanol. Detection was performed by using a turboionspray interface and positive ion multiple reaction monitoring by tandem mass spectrometry. The assay quantifies rivastigmine from 0.25 to 50 ng/mL and its metabolite NAP 226-90 from 0.50 to 25 ng/mL, using human plasma samples of 100 microL. Validation results demonstrate that rivastigmine and metabolite concentrations can be accurately and precisely quantified in human EDTA plasma. This assay is now used to support clinical pharmacologic studies with rivastigmine.
authors.affiliation: Department of Geriatric Medicine, Slotervaart Hospital, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. apsfr@slz.nl
authors.forename: Suzanne V
authors.initials: SV
authors.lastname: Frankfort
authors.forename: Mariët
authors.initials: M
authors.lastname: Ouwehand
authors.forename: Maria J
authors.initials: MJ
authors.lastname: van Maanen
authors.forename: Hilde
authors.initials: H
authors.lastname: Rosing
authors.forename: Linda R
authors.initials: LR
authors.lastname: Tulner
authors.forename: Jos H
authors.initials: JH
authors.lastname: Beijnen
mesh_terms: D000284:Administration, Oral; D001596:Benzylamines / Q000097:blood* / Q000493:pharmacokinetics; D002800:Cholinesterase Inhibitors / Q000097:blood* / Q000493:pharmacokinetics; D002851:Chromatography, High Pressure Liquid; D004492:Edetic Acid; D006801:Humans; D010627:Phenethylamines; D010636:Phenols / Q000097:blood* / Q000493:pharmacokinetics; D048448:Phenylcarbamates / Q000097:blood* / Q000493:pharmacokinetics; D015203:Reproducibility of Results; D000068836:Rivastigmine; D012680:Sensitivity and Specificity; D021241:Spectrometry, Mass, Electrospray Ionization; D053719:Tandem Mass Spectrometry / Q000379:methods*
chemical_list: C494046:3-(1-dimethylaminoethyl)phenol; D001596:Benzylamines; D002800:Cholinesterase Inhibitors; D010627:Phenethylamines; D010636:Phenols; D048448:Phenylcarbamates; D004492:Edetic Acid; D000068836:Rivastigmine